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PROBLEMS & PARADIGMSBroad Chromatin Domains: An Important Facet of
Genome RegulationFrancesco N. Carelli, Garima Sharma, and Julie Ahringer*Chromatin composition differs across the genome, with distinct compositions
characterizing regions associated with different properties and functions.
Whereas many histone modifications show local enrichment over genes or
regulatory elements, marking can also span large genomic intervals defining
broad chromatin domains. Here we highlight structural and functional
features of chromatin domains marked by histone modifications, with a
particular emphasis on the potential roles of H3K27 methylation domains in
the organization and regulation of genome activity in metazoans.1. Introduction
The linear sequence of DNA is compacted into chromatin by
organization into nucleosomes, and functional units of
chromatin can be distinguished by the enrichment of different
histonemodifications and chromatin binding proteins.[1,2] While
defined genomic elements such as promoters and other
regulatory elements are usually associated with local enrichment
for particular histone modifications, recent research has shown
the existence of broad domains of histone modifications that
spread over large genomic regions. Patterns of histone
modifications on genomic elements have been shown to be
similar across species,[3] however, much less is known about the
formation, function, and conservation of broad domains. Here,
we examine work over the last decade or so that has
demonstrated the existence of broad chromatin domains in a
range of organisms. We will focus, in particular, on domains
defined by the methylation of the lysine 27 residue of histone 3
(H3K27me), and discuss functions and relationships with other
histone modifications and with the three-dimensional architec-
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Common
Chromatin domains are extended genomic
intervals characterized by the continuous
enrichment of a given histone modifica-
tion, spanning between tens of kilobases to
megabases in length, and usually encom-
passing multiple genes. Their large size
and relatively uniform basal enrichment
profile distinguish broad chromatin
domains from other histone modifica-
tion-enriched loci, such as extended
H3K4me3 enrichment on individual regu-latory regions[4,5] or collections of narrow peaks at regions with a
high density of regulatory elements, such as super-enhancers.[6]
Chromatin domains have been described in most well studied
metazoan species. A paradigmatic example are the large
domains of H3K27me3 deposited over Hox gene clusters in
mammals and Drosophila.[7–9] These chromatin domains can
span hundreds of kilobases in length, and the Hox genes they
encompass are transcriptionally repressed. Other histone
modifications have also been observed to coat extended
chromatin intervals, such as the large domains of H3K9me2/
3 on mammalian and Drosophila pericentric heterochroma-
tin.[2,10] More recently, large domains of H3K27me2 were
observed in mouse[11] and Drosophila[12] covering up to 70% of
the genome. Thus, the association of one histone modification
with large genomic regions is a common feature in metazoans.3. Broad Chromatin Domains of H3K36me3
and H3K27me3 Define Transcriptionally
Distinct Regions in Caenorhabditis elegans
Recent studies in Caenorhabditis elegans highlighted roles for
broad chromatin domains in genome regulation. Analyses of
patterns of histone modifications in undifferentiated embryo
and differentiated larval stages uncovered a genome-wide
pattern of alternating chromatin domains that have differing
marking and genomic activity (Figure 1A).[13,14] “Active”
domains are highly enriched for H3K36me3-marked genes
expressed in the germ line and usually also widely and stably
expressed across cell types. “Regulated” domains, in contrast,
are characterized by the extended deposition of H3K27me3
over genes and intergenic regions, and are enriched for genes
with temporally, spatially, or environmentally regulated
expression. The regions between active and regulated
domains, termed borders, were shown to have features of
transcription regulation, such as transcription factor bindingAuthors. BioEssays Published by WILEY Periodicals, Inc
www.advancedsciencenews.com www.bioessays-journal.comsites and long intergenic regions, as well as enrichment for
particular repeat elements. The positions of domains largely
overlapped across the two developmental stages assayed,
suggesting that this chromatin organization is a core property
of the genome.
How the domains form and their functional roles are not yet
clear, but intriguingly germ line activities appear to be important.
MES-4 is a germ line and maternally active H3K36me3 histone
methyltransferase that maintains the memory of germ line
transcription.[15] In early embryos, maternally provided MES-4
maintains the H3K36me3 marking of genes that were expressed
in the germ line. MES-4 was shown to act antagonistically with
the C. elegans PRC2-like complex that generates H3K27me3:
when mes-4 was depleted, germ line specific genes acquired
H3K27me3.[13] Studying this interaction at the level of domains,
it was found that active domains contracted and regulated
domains marked by H3K27me3 expanded in embryos with
reduced MES-4,[14] supporting the view that germ line events
play a role in determining domain structure. The association of
features of transcription regulation at the borders between active
and regulated domains suggests that transcription might be
involved in domain separation, although this has not yet been
tested.4. Do Chromatin Domains Exist in Other
Species?
The existence of chromatin domains associated with genes
having either widespread stable or regulated gene expression
across the C. elegans genome raises the question of whether a
similar chromatin organization characterizes other species. The
possibility of active and regulated regions in other metazoans is
supported by the long-known non-random distribution of genes
with similar expression profiles,[16,17] as well as by the overall
similar distribution of chromatin modifications across distantly
related organisms.[3] The first genome-wide analyses of
H3K27me3 modification profiles in Drosophila revealed the
presence of several large chromatin domains, mostly covering
genes involved in developmental processes.[8,9] Despite their
similarity with the regulated domains described in worm, these
domains encompass only a small fraction of the genome.
However, recent work has reported a much more widespread
distribution of H3K27me3 in Drosophila primary spermatocytes
(Figure 1B).[18] In this cell type, the H3K27me3 mark is enriched
over broad regions, a pattern significantly different from that
observed in Drosophila embryos and cell lines. Based on the
relative enrichment of this chromatin modification across the
whole genome, the authors defined thousands of H3K27me3-
enriched and H3K27me3-depleted domains, showing strong
correspondence with polytene chromosome bands and chroma-
tin architecture (see section 7). Intriguingly, the H3K27me3-
depleted domains cover the vastmajority of housekeeping genes,
and are also enriched for a set of chromatin marks associated
with active transcription, including H3K36me3, H3K9ac, and
H3K27ac. In contrast, H3K27me3-enriched domains include
mostly regulated genes with cell-type or tissue-specific expres-
sion that lack chromatin marks classically associated with gene
activity. This result is in agreement with a previous reportBioEssays 2017, 39, 1700124 1700124 (2 of 7)showing that developmentally regulated genes undergoing
active transcription lack histone modifications normally associ-
ated with gene activity,[19] and suggests differential chromatin
control of active and regulated gene expression. Overall, the
domains defined by the relative enrichment of H3K27me3 in
Drosophila spermatocytes are reminiscent of the active and
regulated domains in C. elegans, although this chromatin
organization has not been observed in other tissues or
developmental stages in the fruitfly.
Whether H3K27me3 in mammals defines chromatin
domains similar to those observed in C. elegans is more
uncertain. Early, genome-wide analyses described H3K27me3
enrichment as generally confined to narrow regulatory regions
(except for a few broad domains) in pluripotent mouse ES cells
and lineage-committed embryonic fibroblasts (MEF).[20] In these
cells, H3K27me3 was found either alone or associated with
H3K4me3 at thousands of promoter regions, and its presence
associated with transcriptional repression. A subsequent study
performed on similar MEF cell lines found that most H3K27me3
peaks were contained in broad H3K27me3 domains, termed
BLOCs, spanning on average 43 kbp in length.[21] The authors
also showed that at a larger scale, H3K27me3 is enriched over
megabase-sized domains strongly overlapping with regions of
high gene density and to the typical light Giemsa banding
pattern in mouse metaphase chromosomes (R-bands), and anti-
correlated with large regions of H3K9me3 and H4K20me3.
Subsequent studies further supported the broad distribution of
H3K27me3 in fully differentiated cells of mouse and human,
where it was observed that H3K27me3 covers up to 40% of the
genome in differentiated cells, compared to 8% in pluripotent
samples (Figure 1C).[22,23] Therefore, in contrast to the focal
enrichment initially described in ES cells, more recent studies
additionally revealed a broad distribution of H3K27me3 over
large domains in mammalian lineage-committed and differen-
tiated cell types.
More recently, the development of new, low input ChIP-seq
protocols has allowed the analysis of histone modification
distributions in samples with limited starting material.[24] Using
the STAR-ChIP technique, Zheng et al. profiled H3K27me3 in
mouse oocytes and early embryos, observing that H3K27me3 is
found in broad domains from oocytes to pre-implantation
blastocysts. Later, in post-implantation E6.5 epiblasts,
H3K27me3 shows a more punctate pattern, similar to that seen
in ES cells (Figure 1C).[25] In sum, current results indicate that
H3K27me3 is generally found over large chromatin domains in
most mammalian cell types. The more focal distribution seen
in ES cells was proposed to be due to a more dynamic chromatin
state based on the observation that these cells have a wide
distribution of H2AZ.[22,26]
The aformentioned studies consistently found that transcrip-
tion of genes covered by H3K27me3 domains is repressed,
supporting a negative regulatory role for this mark in
differentiated cells. Nonetheless, it is as yet unclear whether
the broad domains defined by H3K27me3 distinguish genes
with regulated expression from those with wide stable
expression, and to what extent the domains identify the same
genomic regions across different cell types or developmental
stages. Moreover, it is worth noting that there appear to be
species-specific differences in broad domain marking. Despite© 2017 The Authors. BioEssays Published by WILEY Periodicals, Inc
Figure 1. Histone modification distributions in C. elegans, D. melanogaster, and M. musculus. A) In C. elegans, active (magenta) and regulated (black)
domains from Ref. [14] overlapmutually exclusive enrichments of H3K36me3 andH3K27me3 previously noted in Ref. [13] B) Histonemodification profiles
in Drosophila melanogaster. H3K27me3 is distributed over large domains in primary spermatocytes, and its profile closely resembles the profile of
H3K27me2 in the embryo-derived Kc167 cell line. In late embryonic and L3 larval stages, H3K27me3 covers fewer domains. Some domains are still
present (e.g., shaded region), usually overlapping developmentally regulated genes such as the Optix gene (highlighted in red). C) In mouse oocytes and
pre-implantation embryos (e.g., 2-cell embryos), H2K27me3 is found over broad domains that occupy the same regions. In post-implantation epiblasts
and embryo-derived ESCs, H3K27me3 is focally enriched at regulatory elements. The H3K27me3 profile changes again in more differentiated adult
tissues; in adult organs, focal regions are present, but in addition broad regions of H3K27me3 also cover large portions of the genome, including gene
bodies and intergenic regions. C. elegans data are from modENCODE (see Ref. [3]). Drosophila H3K27me3 in primary spermatocytes are from Ref. [18]
(GSE85502), H3K27me2 in Kc-167 cells are from Ref. [33] (GSE32825), and H3K27me3 from embryos and larvae from Ref. [3] Mouse H3K27me3 in
oocytes, 2-cell embryos, and epiblasts are from Ref. [25] (GSE76687). Mouse H3K27me3 in ESCs are from Ref. [11] (GSE51006), in adult liver are from
Ref. [65] (ENCFF001KMV, ENCFF001KMW). Images of C. elegans (by Bob Goldstein), D. melanogaster (by Andre Karwath) and mouse are under a CC-
BY-SA license.
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tions, indeed, there are significant differences in the abundance
of some histone modifications between C. elegans, Drosophila,
and mammals. For example, trimethylation is the most
abundant modification at the H3K27 residue in C. elegans
across all developmental stages.[27] Instead, in Drosophila
larvae[28] and mouse ESCs,[29] the H3K27 residue is mostly
dimethylated. In these species, H3K27me2 domains cover vast
portions of the genome and repress transcription of the
underlying sequences.[11,12] Notably, there is a remarkable
correspondence between H3K27me2 domains in Drosophila
Kc167 cells and the H3K27me3 domains in primary sperma-
tocytes[18] (Figure 1B), suggesting that different H3K27
methylation states may define these chromatin domains at
different stages of Drosophila development.5. Domains of H3K9 and H3K4 Methylated
Chromatin
Domains of H3K9 methylated chromatin, often associated with
gene repression and/or repetitive element silencing, have been
shown to exist in multiple species. A well-known example is the
chromatin surrounding centromeres (pericentromeric hetero-
chromatin) where large, multi-megabase domains of H3K9
methylated chromatin are associated with DNA that is gene poor
and highly enriched for repetitive sequences.[30] There, loss of
H3K9 methylation leads to transcription of repetitive sequences
and impaired centromeric function.[30]
Domains of H3K9 methylated chromatin also form outside of
pericentric heterochromatin. An early study showed that human
and mouse chromatin contains large regions modified by
H3K9me2, termed LOCKs, which were observed to span regions
up to 4.9Mbp.[10] LOCKs appeared to be associated with
differentiation, as they covered a larger fraction of the genome
of differentiated cells (10–36%) compared to undifferentiated ES
cells (4%). LOCKs were dependent on the histone methyl-
transferase G9a and the genes within them generally repressed.
Interestingly, LOCKs were also significantly reduced in cancer
cells. The results support a role for H3K9me2 domains in
regulating cell type specific gene expression. Mammalian
genomes also contain large non-pericentric domains of
H3K9me3, which like H3K9me2, are more prevalent in
differentiated cells than undifferentiated cells.[31] They are
associated with lineage specific gene repression and their
presence is inhibitory for reprogramming.[31,32]
In Drosophila, as in mammals, broad domains of H3K9me2
are found within euchromatic regions, in addition to high levels
of H3K9me2 and H3K9me3 in pericentric heterochromatin.[33]
Some of the broad H3K9me2 domains were found to be
common to all cell types examined whereas others were cell type
specific. The functional roles of the broad H3K9me2 domains is
as yet unclear, but there may be diversity of function because
some domains cover genes that are well expressed, but within
other domains, genes are transcriptionally silent.[33]
In contrast to mammals and Drosophila, C. elegans chromatin
does not contain large megabase scale domains of H3K9me2 or
H3K9me3, likely due its holocentric chromosomes. Rather
than having a single centromere surrounded by pericentricBioEssays 2017, 39, 1700124 1700124 (4 of 7)heterochromatin, centromeres are distributed along the chro-
mosomes and pericentric heterochromatin is not apparent. Most
H3K9 methylation is present on distal arm regions of
autosomes.[34,35] H3K9me3 domains are on average 30 kbp,
and similar to other organisms, H3K9me3 covers a larger
fraction of the genome of differentiated larvae compared to
undifferentiated embryos.[3] H3K9 methylation is associated
with transcriptional repression, as loss of the enzymes that
generate methylated H3K9 leads to derepression of genes and
repetitive elements.[36,37] C. elegans H3K9me3 domains also
differ from those in other animals in that they generally also
contain H3K27me3.[3]
Domains of chromatin methylated on H3K27 or H3K9 are
amongst the best known examples of chromatin domains, but
methylated H3K4, usually associated with gene activity, has also
been shown to form broad domains. Broad H3K4 di- and tri-
methylated domains are located at HoxA and HoxB loci, where
they were observed only in cells in which these genes are
specifically expressed.[38] However, broad H3K4me3 domains
are not always associated with gene activity. Recent studies found
that broad H3K4me3 domains cover 22% of the genome in
mouse oocytes, where they significantly overlapped genes and
putative regulatory elements associated with subsequent zygotic
genome activation (ZGA).[24,39] Mapping at the 2- and 8-cell stage
showed that the broad H3K4me3 domains were progressively
lost, leaving punctate peaks of H3K4me3 at promoters of ZGA
genes. The broad H3K4me3 domains in oocytes appear to be
repressive, because depletion of the H3K4 demethylases
KDM5A/B resulted in their persistence at 2- and 8-cell stages,
the downregulation of ZGA genes, and the failure of embryo
development.[39] In summary, multiple lines of evidence indicate
that broad chromatin domains, or the proteins responsible for
their deposition, have roles in the control of transcriptional
processes.6. Mechanisms of Domain Formation
A common feature associated with chromatin domains is a
mechanism enabling the histone modification to spread.
Histone methyltransferases are often associated with adaptor
proteins or contain protein domains that can bind the histone
modification generated and hence aid in expanding the mark to
neighboring nucleosomes. For example, SUV39H2 contains a
chromodomain that recognizes methylated H3K9.[40] Hetero-
chromatin Protein 1 (HP1), which also harbors a chromodomain
that binds H3K9me2 and H3K9me3, recruits SUV39H2,
forming a feedback loop to spread H3K9me2/H3K9me3 along
the chromatin.[41] A similar mechanism for H3K9 spreading
occurs in Schizosaccharomyces pombe centromeric chromatin.[42]
The spreading of H3K27 methylation is dependent on the
ability of EED in the PRC2 complex to bind methylated H3K27
via its WD40 domain. EED bound H3K27me3 is sensed by the
stimulatory recognition motif (SRM) of EZH2 and stimulates its
methyltransferase activity, allowing H3K27me3 to be propagated
along the chromatin.[43] H3K4me3 and H3K36me3 modifica-
tions, associated with gene activity, have been shown to
allosterically inhibit the methylation activity of PRC2 via
SUZ12[44,45] thus limiting the spread of H3K27me3 domains.© 2017 The Authors. BioEssays Published by WILEY Periodicals, Inc
www.advancedsciencenews.com www.bioessays-journal.comThis phenomenon may explain the expansion of C. elegans
H3K27me3 domains when the H3K36 methyltransferase MES-4
is inhibited.[13,14]7. Chromatin Domains and 3D Genome
Organization
Segmentation of chromatin into broad linear domains resem-
bles the organization of genomes into topologically associated
domains (TADs) (for reviews on this topic, seeRefs. [46,47]). TADs
are contiguous genomic regions defined by strong physical self-
interactions and their relative insulation from other sequences,
as revealed by high-throughput chromosome conformation
capture techniques such as Hi-C.[48] The genomes of mammals
and Drosophila have been shown to be spatially organized into
TADs usually comprising 1–10 genes,[49–51] whereas, the three-
dimensional architecture of the C. elegans genome appears to
differ significantly. Indeed, a Hi-C physical interaction map
defined self-interacting TAD-like domains primarily on the X-
chromosome in C. elegans.[52] These megabase-scale domains
contain an average of200 genes and their structure is regulated
by dosage compensation. The lack of a C. elegans TAD
architecture similar to that in Drosophila and mouse might be
related to the apparent lack of architectural insulator proteins in
C. elegans, including CTCF[53], which is important for TAD
definition, at least in mammals.[54] Interestingly, topological
domains in fruitfly and mammals have characteristics similar to
C. elegans chromatin domains, since chromatin marking across a
TAD is often relatively uniform[47] and TAD positions are highly
conserved across different cell types.[55] These observations
suggest that there may be a functional overlap between the two
types of genome organization. Are active/regulated chromatin
domains and topological domains separate entities, possibly
fulfilling similar roles in distinct species? Or, if chromatin
domains characterize the genomes of other metazoans, how do
they correlate with the three-dimensional genome architecture?
Recent work in Drosophila suggests a strong correlation
between broad H3K27me3 domains in primary spermatocytes
and three-dimensional chromatin organization.[18] Active chro-
matin domains (lowH3K27me3) show a very strong overlap with
TAD boundaries, and are characterized by significantly more
short-range physical interactions compared to the high
H3K27me3 domains. This result agrees with previous reports
showing that TADs overlapping transcriptionally active domains,
which encompass most of the stably expressed genes in
Drosophila,[56] have a peculiar contact structure characterized
by generally close intra–domain interactions.[50] Although the
chromatin and topological domains compared in this work were
obtained from different cell types, a significant overlap was
observed between the H3K27me3 profile in primary sperma-
tocytes and the H3K27me2 landscape in the Kc167 cells from
which the Hi-C data were produced. It will be therefore
interesting to study whether different methylation levels of the
H3K27 residue might reflect the topological architecture of the
genome in other tissues and developmental stages in the fruitfly.
Recent work on the 3D architecture of mouse gametes and
early embryos also found a correlation between chromatin
architecture and broad H3K27me3 domains. From the zygote toBioEssays 2017, 39, 1700124 1700124 (5 of 7)the 8-cell stage,[57] broad H3K27me3 domains were observed to
cover so-called “B” compartments, genomic regions that interact
in 3D and that are associated with inactive chromatin.[48] Notably,
at E6.5, when strong broad domains of H3K27me3 are no longer
present and instead this modification has a punctate pattern at
regulatory elements (see section 4),[25] H3K27me3 is enriched in
the “A” (active) compartment, similar to the pattern in
lymphoblastoid cell lines.[48,57]
If confirmed, these observations would support a unified
model in which the histone modification landscape matches
chromatin topology, raising questions regarding the interplay
between the two levels of genome organization. For example, it
will be important to define whether chromatin state determines
the physical insulation of domains, or alternatively genome
topology constrains and drives the deposition of specific histone
marks. The latter scenario, based on current data, is unlikely.
Indeed, although previous reports suggested that CTCF might
actively delimit H3K27me3 domains,[58] more recent work
revealed that this protein, directly involved in the definition of
TADs in mammals, does not constrain the spreading of
H3K27me3 to neighboring regions.[54,59] On the other hand,
there is initial evidence for a role of chromatin modifications or
chromatin modifiers in the definition of TADs. A recent study
focused on the onset of zygotic transcription in early Drosophila
embryos showed that some histone modifications were
significantly enriched at future TAD borders before the
formation of topological domains, suggesting that chromatin
modifications might directly or indirectly define chromatin
topology.[60] Nonetheless, reliance of TAD formation upon
chromatin modifications might be expected to involve the
conservation of a given chromatin state throughout organismal
development. In this respect, the finding that germ line
chromatin marking is relevant to chromatin domain structure
in C. elegans and Drosophila suggests a potential mechanism of
transmission of domain information.[13,14,18,61] Whether certain
histone modifications are stably found at the same genomic loci
during the life cycle of an organism is currently unclear, and
therefore further work is needed to define the profile of more
chromatin modifications during development, as well as their
potential link with the establishment of topological domains.8. Conclusions and Future Directions
In summary, different histone modifications form broad
chromatin domains, and such domains appear to be functionally
important in genome regulation, but important details about
their biology are still missing. For example, despite the
similarities in chromatin domain properties in different species,
it is as yet unclear to what extent they are shared traits in
metazoans. The apparent conservation of active and regulated
domain structures at different stages of C. elegans development,
indeed, contrasts with the more dynamic H3K27me3 patterns
during Drosophila and mouse development. Another aspect that
will require further investigation is their epigenetic role. The
structure of H3K27me3 chromatin domains makes them ideal
candidate for the epigenetic transmission of gene regulation
control,[62] and recent experimental work supports an epigenetic
role for this histone mark in animals.[60,63]© 2017 The Authors. BioEssays Published by WILEY Periodicals, Inc
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domains, attention needs to be given to technical aspects of their
study.Guidelines forChIP-seqanalyses, suchas thosedefinedbythe
ENCODE consortium, have been optimized for the identification of
narrow peaks of enrichment,[64] but datasets fulfilling these
guidelines often have insufficient depth of coverage for analyses
of broad domains, where enrichment levels are relatively low.
Moreover, a uniform computational approach for delineating broad
domains would facilitate their comparison between cell types and
species. These improvements, coupled to more comprehensive
profiling of chromatin modifications, perturbation analyses, and
manipulation of domain structures using genome editing, will help
uncover the conservation, roles and regulation of broad chromatin
domains in the control of genome activity.Acknowledgements
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